

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.22106003 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.22106003 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.00016219 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.00016219 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.99057666 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.84528473 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 4.73866569 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.48574610 |
| 9 | proteasome assembly (GO:0043248) | 4.38985815 |
| 10 | complement activation, alternative pathway (GO:0006957) | 4.34735086 |
| 11 | cysteine metabolic process (GO:0006534) | 4.34085555 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 4.30172968 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.23128925 |
| 14 | urea cycle (GO:0000050) | 4.07641505 |
| 15 | urea metabolic process (GO:0019627) | 4.07641505 |
| 16 | bile acid biosynthetic process (GO:0006699) | 4.06831909 |
| 17 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.04489750 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.03180220 |
| 19 | plasma lipoprotein particle clearance (GO:0034381) | 3.95973672 |
| 20 | respiratory chain complex IV assembly (GO:0008535) | 3.95395162 |
| 21 | valine metabolic process (GO:0006573) | 3.94705059 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 3.92895677 |
| 23 | lysine catabolic process (GO:0006554) | 3.89649815 |
| 24 | lysine metabolic process (GO:0006553) | 3.89649815 |
| 25 | keratinocyte development (GO:0003334) | 3.87984460 |
| 26 | positive regulation of lipid catabolic process (GO:0050996) | 3.86348141 |
| 27 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.86187569 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.84500529 |
| 29 | protein carboxylation (GO:0018214) | 3.84500529 |
| 30 | kynurenine metabolic process (GO:0070189) | 3.83323457 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.80682014 |
| 32 | tryptophan catabolic process (GO:0006569) | 3.80682014 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 3.80682014 |
| 34 | regulation of protein activation cascade (GO:2000257) | 3.79173236 |
| 35 | lactate metabolic process (GO:0006089) | 3.78069089 |
| 36 | platelet dense granule organization (GO:0060155) | 3.75935107 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 3.74929269 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 3.74221381 |
| 39 | regulation of sequestering of triglyceride (GO:0010889) | 3.72351667 |
| 40 | glyoxylate metabolic process (GO:0046487) | 3.71281641 |
| 41 | acylglycerol homeostasis (GO:0055090) | 3.70631207 |
| 42 | triglyceride homeostasis (GO:0070328) | 3.70631207 |
| 43 | regulation of complement activation (GO:0030449) | 3.63359388 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 3.62595723 |
| 45 | tryptophan metabolic process (GO:0006568) | 3.62501612 |
| 46 | reverse cholesterol transport (GO:0043691) | 3.60601061 |
| 47 | homocysteine metabolic process (GO:0050667) | 3.60400497 |
| 48 | bile acid metabolic process (GO:0008206) | 3.59923651 |
| 49 | fatty acid beta-oxidation (GO:0006635) | 3.58690850 |
| 50 | regulation of glucokinase activity (GO:0033131) | 3.55051240 |
| 51 | regulation of hexokinase activity (GO:1903299) | 3.55051240 |
| 52 | macromolecular complex remodeling (GO:0034367) | 3.54793546 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 3.54793546 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 3.54793546 |
| 55 | acetyl-CoA metabolic process (GO:0006084) | 3.54356277 |
| 56 | fatty acid oxidation (GO:0019395) | 3.54009687 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 3.53507144 |
| 58 | positive regulation of fatty acid oxidation (GO:0046321) | 3.49846759 |
| 59 | lipid oxidation (GO:0034440) | 3.49043806 |
| 60 | fatty acid catabolic process (GO:0009062) | 3.44489932 |
| 61 | triglyceride catabolic process (GO:0019433) | 3.43767670 |
| 62 | phospholipid efflux (GO:0033700) | 3.43691783 |
| 63 | cullin deneddylation (GO:0010388) | 3.42195515 |
| 64 | tyrosine metabolic process (GO:0006570) | 3.41917948 |
| 65 | xenobiotic catabolic process (GO:0042178) | 3.41166948 |
| 66 | cytochrome complex assembly (GO:0017004) | 3.40902853 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.40283310 |
| 68 | acylglycerol catabolic process (GO:0046464) | 3.39867118 |
| 69 | neutral lipid catabolic process (GO:0046461) | 3.39867118 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39310854 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.35521547 |
| 72 | DNA deamination (GO:0045006) | 3.35341362 |
| 73 | coenzyme catabolic process (GO:0009109) | 3.32884512 |
| 74 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.31645664 |
| 75 | response to pheromone (GO:0019236) | 3.30144239 |
| 76 | serine family amino acid catabolic process (GO:0009071) | 3.30035282 |
| 77 | monocarboxylic acid catabolic process (GO:0072329) | 3.28415698 |
| 78 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.27508088 |
| 79 | positive regulation of protein autophosphorylation (GO:0031954) | 3.25351500 |
| 80 | aromatic amino acid family metabolic process (GO:0009072) | 3.25293330 |
| 81 | S-adenosylmethionine metabolic process (GO:0046500) | 3.24536669 |
| 82 | alpha-amino acid catabolic process (GO:1901606) | 3.24284567 |
| 83 | fatty acid transmembrane transport (GO:1902001) | 3.22732538 |
| 84 | short-chain fatty acid metabolic process (GO:0046459) | 3.22018603 |
| 85 | cholesterol efflux (GO:0033344) | 3.21283836 |
| 86 | positive regulation of actin filament depolymerization (GO:0030836) | 3.20945241 |
| 87 | ethanol oxidation (GO:0006069) | 3.19797658 |
| 88 | epoxygenase P450 pathway (GO:0019373) | 3.17846883 |
| 89 | cellular amino acid catabolic process (GO:0009063) | 3.17753670 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.16810610 |
| 91 | bile acid and bile salt transport (GO:0015721) | 3.15666149 |
| 92 | protein deneddylation (GO:0000338) | 3.15540299 |
| 93 | negative regulation of sterol transport (GO:0032372) | 3.14693902 |
| 94 | negative regulation of cholesterol transport (GO:0032375) | 3.14693902 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.12327723 |
| 96 | branched-chain amino acid catabolic process (GO:0009083) | 3.11346435 |
| 97 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.10275052 |
| 98 | regulation of cholesterol storage (GO:0010885) | 3.08880478 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.07377640 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 3.06607804 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.06176297 |
| 102 | organic acid catabolic process (GO:0016054) | 3.06176297 |
| 103 | regulation of cholesterol metabolic process (GO:0090181) | 3.06101970 |
| 104 | negative regulation of lipase activity (GO:0060192) | 3.05139991 |
| 105 | signal peptide processing (GO:0006465) | 3.04875081 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.03986496 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.03986496 |
| 108 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.03607975 |
| 109 | branched-chain amino acid metabolic process (GO:0009081) | 3.03385055 |
| 110 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.02736711 |
| 111 | ketone body metabolic process (GO:1902224) | 3.02015649 |
| 112 | regulation of sulfur metabolic process (GO:0042762) | 3.00785613 |
| 113 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.99042663 |
| 114 | peptidyl-cysteine modification (GO:0018198) | 2.98357014 |
| 115 | oxaloacetate metabolic process (GO:0006107) | 2.97169837 |
| 116 | glutamate metabolic process (GO:0006536) | 2.96220321 |
| 117 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.95180098 |
| 118 | cellular glucuronidation (GO:0052695) | 2.95090488 |
| 119 | biotin metabolic process (GO:0006768) | 2.94627808 |
| 120 | fibrinolysis (GO:0042730) | 2.94481422 |
| 121 | thioester biosynthetic process (GO:0035384) | 2.93437497 |
| 122 | acyl-CoA biosynthetic process (GO:0071616) | 2.93437497 |
| 123 | carnitine metabolic process (GO:0009437) | 2.92118469 |
| 124 | positive regulation of glycolytic process (GO:0045821) | 2.91572312 |
| 125 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.91239385 |
| 126 | inositol phosphate catabolic process (GO:0071545) | 2.88576375 |
| 127 | DNA double-strand break processing (GO:0000729) | 2.85535970 |
| 128 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.85093983 |
| 129 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.82551727 |
| 130 | mannosylation (GO:0097502) | 2.82245880 |
| 131 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.77381467 |
| 132 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.77381467 |
| 133 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.77381467 |
| 134 | negative regulation of neurological system process (GO:0031645) | 2.75835462 |
| 135 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.74592532 |
| 136 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.74592532 |
| 137 | protein complex biogenesis (GO:0070271) | 2.73401170 |
| 138 | zinc ion transport (GO:0006829) | 2.71478258 |
| 139 | transepithelial transport (GO:0070633) | 2.71358263 |
| 140 | L-fucose metabolic process (GO:0042354) | 2.71208956 |
| 141 | L-fucose catabolic process (GO:0042355) | 2.71208956 |
| 142 | fucose catabolic process (GO:0019317) | 2.71208956 |
| 143 | glucuronate metabolic process (GO:0019585) | 2.68452583 |
| 144 | uronic acid metabolic process (GO:0006063) | 2.68452583 |
| 145 | tricarboxylic acid cycle (GO:0006099) | 2.64320155 |
| 146 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.62445315 |
| 147 | regulation of cofactor metabolic process (GO:0051193) | 2.57951200 |
| 148 | regulation of coenzyme metabolic process (GO:0051196) | 2.57951200 |
| 149 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.56199167 |
| 150 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.56199167 |
| 151 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.56035123 |
| 152 | dopamine transport (GO:0015872) | 2.54626279 |
| 153 | vitamin biosynthetic process (GO:0009110) | 2.54544976 |
| 154 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.54424136 |
| 155 | arginine catabolic process (GO:0006527) | 2.54356678 |
| 156 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.54316017 |
| 157 | polyol catabolic process (GO:0046174) | 2.54038560 |
| 158 | glutathione derivative metabolic process (GO:1901685) | 2.53231668 |
| 159 | glutathione derivative biosynthetic process (GO:1901687) | 2.53231668 |
| 160 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.52298118 |
| 161 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.50883882 |
| 162 | L-methionine salvage (GO:0071267) | 2.49594109 |
| 163 | L-methionine biosynthetic process (GO:0071265) | 2.49594109 |
| 164 | amino acid salvage (GO:0043102) | 2.49594109 |
| 165 | inositol phosphate dephosphorylation (GO:0046855) | 2.48777393 |
| 166 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.48777393 |
| 167 | sterol biosynthetic process (GO:0016126) | 2.48313558 |
| 168 | negative regulation of acute inflammatory response (GO:0002674) | 2.46047444 |
| 169 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.44628328 |
| 170 | kidney morphogenesis (GO:0060993) | 2.44620105 |
| 171 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.44420552 |
| 172 | isotype switching (GO:0045190) | 2.44198343 |
| 173 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.44198343 |
| 174 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.44198343 |
| 175 | cholesterol biosynthetic process (GO:0006695) | 2.43654653 |
| 176 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.43451966 |
| 177 | quinone metabolic process (GO:1901661) | 2.42903953 |
| 178 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.42874014 |
| 179 | nucleotide transmembrane transport (GO:1901679) | 2.42671821 |
| 180 | arginine metabolic process (GO:0006525) | 2.41948223 |
| 181 | heme transport (GO:0015886) | 2.41228122 |
| 182 | peptidyl-histidine modification (GO:0018202) | 2.40087687 |
| 183 | response to nitrosative stress (GO:0051409) | 2.39995012 |
| 184 | terpenoid biosynthetic process (GO:0016114) | 2.39383361 |
| 185 | peroxisome fission (GO:0016559) | 2.39357039 |
| 186 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.39130236 |
| 187 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.39130236 |
| 188 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.38880959 |
| 189 | drug catabolic process (GO:0042737) | 2.36598205 |
| 190 | protein K6-linked ubiquitination (GO:0085020) | 2.35743532 |
| 191 | lipid particle organization (GO:0034389) | 2.33719517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.90998361 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.52726660 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.74133108 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.95795983 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.70108941 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.78835340 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.76522171 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.40222486 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.08909213 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.99384623 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.94506871 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.68210100 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.66960288 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.59541534 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.57099886 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54305023 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.52599598 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.46698789 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.35982869 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21752490 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.18797537 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16701988 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11397511 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09494008 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03705693 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.02541774 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00776388 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95473286 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95084578 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87809465 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79652011 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.74410481 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71638033 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67169339 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66122515 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65493095 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65069680 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63850358 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.63232021 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62633352 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61276993 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.60433994 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57129765 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57068848 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55976899 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55511677 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54086559 |
| 48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54084266 |
| 49 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.52086760 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51369318 |
| 51 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.48862459 |
| 52 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.48862459 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44365042 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44118784 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42844836 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41987350 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41316606 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40301742 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39541721 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38713647 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37241269 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37241269 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37078202 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37070539 |
| 65 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35749498 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34525553 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34525553 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.34482177 |
| 69 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.33405219 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33266450 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33123110 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32904054 |
| 73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32829017 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32518569 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31598686 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30772616 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.30596867 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.30223258 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.29634153 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28812785 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28436035 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27119175 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26397415 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26282528 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26105120 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24120411 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23824533 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23652816 |
| 89 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23378156 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22967136 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22777110 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22604166 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22551459 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21260701 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20663289 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.20511859 |
| 97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20374580 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19988325 |
| 99 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19988325 |
| 100 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.19535257 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19484249 |
| 102 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19277132 |
| 103 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18139582 |
| 104 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17744463 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17013420 |
| 106 | AR_20517297_ChIP-Seq_VCAP_Human | 1.16500459 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16185514 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15997190 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15182341 |
| 110 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14531100 |
| 111 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13635436 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.13567833 |
| 113 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13173329 |
| 114 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12930536 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12322740 |
| 116 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11534146 |
| 117 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11143006 |
| 118 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10948578 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10839995 |
| 120 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10066757 |
| 121 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.09967451 |
| 122 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08961453 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08260742 |
| 124 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08097770 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07666993 |
| 126 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07532378 |
| 127 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05856976 |
| 128 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04552022 |
| 129 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04205917 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03543684 |
| 131 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.03405436 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02943488 |
| 133 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02727901 |
| 134 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01886020 |
| 135 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.01873916 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98092516 |
| 137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97188574 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93433374 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93079698 |
| 140 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91629264 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91539023 |
| 142 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91016780 |
| 143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88338856 |
| 144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87897784 |
| 145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87761595 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85198809 |
| 147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.83246536 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82777458 |
| 149 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82491313 |
| 150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82379301 |
| 151 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82095489 |
| 152 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81197354 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80168100 |
| 154 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79283788 |
| 155 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77616650 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77530921 |
| 157 | RXR_22108803_ChIP-Seq_LS180_Human | 0.74816223 |
| 158 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74720093 |
| 159 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73860620 |
| 160 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73237002 |
| 161 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72742311 |
| 162 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72408688 |
| 163 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70188691 |
| 164 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.68077765 |
| 165 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68005519 |
| 166 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67933596 |
| 167 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.67614976 |
| 168 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66962991 |
| 169 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66480810 |
| 170 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66421288 |
| 171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66070596 |
| 172 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.66034680 |
| 173 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.65670032 |
| 174 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.64875313 |
| 175 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64087112 |
| 176 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.63753870 |
| 177 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.63421606 |
| 178 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.63421606 |
| 179 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63355669 |
| 180 | ATF3_27146783_Chip-Seq_COLON_Human | 0.62688654 |
| 181 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61074907 |
| 182 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.60775755 |
| 183 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.60055182 |
| 184 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59339930 |
| 185 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.58899794 |
| 186 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58842035 |
| 187 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58552768 |
| 188 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.58289486 |
| 189 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58212312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.06028662 |
| 2 | MP0005360_urolithiasis | 5.46943348 |
| 3 | MP0005365_abnormal_bile_salt | 4.65282716 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.54258040 |
| 5 | MP0000372_irregular_coat_pigmentation | 4.07443683 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.82052509 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.46291405 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.77298970 |
| 9 | MP0003252_abnormal_bile_duct | 2.70786801 |
| 10 | MP0002102_abnormal_ear_morphology | 2.63596588 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.62988917 |
| 12 | MP0006054_spinal_hemorrhage | 2.58371803 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.55326745 |
| 14 | MP0009840_abnormal_foam_cell | 2.49590626 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.45925355 |
| 16 | MP0004130_abnormal_muscle_cell | 2.45751934 |
| 17 | MP0005332_abnormal_amino_acid | 2.34642873 |
| 18 | MP0005083_abnormal_biliary_tract | 2.33966920 |
| 19 | MP0000516_abnormal_urinary_system | 2.26272347 |
| 20 | MP0005367_renal/urinary_system_phenotyp | 2.26272347 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.22204544 |
| 22 | MP0005408_hypopigmentation | 2.19903334 |
| 23 | MP0005670_abnormal_white_adipose | 2.19136294 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 2.04873263 |
| 25 | MP0003195_calcinosis | 2.04576977 |
| 26 | MP0000609_abnormal_liver_physiology | 1.95459801 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.92610920 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.92585141 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.91008694 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.89902876 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.87299931 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.83610038 |
| 33 | MP0003718_maternal_effect | 1.81708842 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.80806790 |
| 35 | MP0002938_white_spotting | 1.78928792 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.75040103 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.71898191 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.69611068 |
| 39 | MP0005171_absent_coat_pigmentation | 1.68182058 |
| 40 | MP0002163_abnormal_gland_morphology | 1.61838478 |
| 41 | MP0009697_abnormal_copulation | 1.61243512 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.59702420 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.59578143 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.58437562 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57654803 |
| 46 | MP0002090_abnormal_vision | 1.57327828 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.55846948 |
| 48 | MP0000604_amyloidosis | 1.54546352 |
| 49 | MP0003787_abnormal_imprinting | 1.53540428 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.48614809 |
| 51 | MP0000427_abnormal_hair_cycle | 1.47215965 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.46010610 |
| 53 | MP0002254_reproductive_system_inflammat | 1.44942968 |
| 54 | MP0003786_premature_aging | 1.44836232 |
| 55 | MP0004043_abnormal_pH_regulation | 1.41153737 |
| 56 | MP0002971_abnormal_brown_adipose | 1.40552823 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.39854856 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.37632673 |
| 59 | MP0005253_abnormal_eye_physiology | 1.37550610 |
| 60 | MP0003186_abnormal_redox_activity | 1.36508646 |
| 61 | MP0008058_abnormal_DNA_repair | 1.34225431 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.33848692 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.32644904 |
| 64 | MP0005275_abnormal_skin_tensile | 1.32619847 |
| 65 | MP0005535_abnormal_body_temperature | 1.31514849 |
| 66 | MP0001764_abnormal_homeostasis | 1.25487233 |
| 67 | MP0003011_delayed_dark_adaptation | 1.25461306 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.23962191 |
| 69 | MP0003329_amyloid_beta_deposits | 1.22515758 |
| 70 | MP0005395_other_phenotype | 1.22067349 |
| 71 | MP0004215_abnormal_myocardial_fiber | 1.21304609 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.20935236 |
| 73 | MP0001756_abnormal_urination | 1.20908608 |
| 74 | MP0005334_abnormal_fat_pad | 1.20879463 |
| 75 | MP0003724_increased_susceptibility_to | 1.19492055 |
| 76 | MP0009764_decreased_sensitivity_to | 1.18998699 |
| 77 | MP0003868_abnormal_feces_composition | 1.18414200 |
| 78 | MP0008775_abnormal_heart_ventricle | 1.18401110 |
| 79 | MP0010678_abnormal_skin_adnexa | 1.17603494 |
| 80 | MP0003136_yellow_coat_color | 1.17526253 |
| 81 | MP0001984_abnormal_olfaction | 1.17071138 |
| 82 | MP0000647_abnormal_sebaceous_gland | 1.15887420 |
| 83 | MP0003690_abnormal_glial_cell | 1.14570041 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 1.14278722 |
| 85 | MP0005451_abnormal_body_composition | 1.13321331 |
| 86 | MP0002822_catalepsy | 1.12898364 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.10449019 |
| 88 | MP0005448_abnormal_energy_balance | 1.01824809 |
| 89 | MP0001324_abnormal_eye_pigmentation | 1.01552625 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 1.01414688 |
| 91 | MP0005646_abnormal_pituitary_gland | 1.00081339 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.98753343 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 0.98635294 |
| 94 | MP0009115_abnormal_fat_cell | 0.98297754 |
| 95 | MP0002796_impaired_skin_barrier | 0.97961121 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.97451145 |
| 97 | MP0000371_diluted_coat_color | 0.96866179 |
| 98 | MP0004484_altered_response_of | 0.95571355 |
| 99 | MP0010352_gastrointestinal_tract_polyps | 0.91262071 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.90053629 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.89932138 |
| 102 | MP0000598_abnormal_liver_morphology | 0.89866693 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.89510151 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.86606222 |
| 105 | MP0005410_abnormal_fertilization | 0.85835492 |
| 106 | MP0003075_altered_response_to | 0.84559965 |
| 107 | MP0008469_abnormal_protein_level | 0.84463363 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.83760564 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.83753657 |
| 110 | MP0000613_abnormal_salivary_gland | 0.83628818 |
| 111 | MP0005164_abnormal_response_to | 0.82384969 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.82259312 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.81054548 |
| 114 | MP0004147_increased_porphyrin_level | 0.80844326 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.78883181 |
| 116 | MP0004381_abnormal_hair_follicle | 0.78794603 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.78714860 |
| 118 | MP0001881_abnormal_mammary_gland | 0.78055693 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.78030735 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.77736899 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.77311644 |
| 122 | MP0009763_increased_sensitivity_to | 0.77024663 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.76805864 |
| 124 | MP0003959_abnormal_lean_body | 0.76766793 |
| 125 | MP0001661_extended_life_span | 0.76269697 |
| 126 | MP0005166_decreased_susceptibility_to | 0.75973990 |
| 127 | MP0003283_abnormal_digestive_organ | 0.75428545 |
| 128 | MP0003436_decreased_susceptibility_to | 0.73527411 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.72886275 |
| 130 | MP0002060_abnormal_skin_morphology | 0.72267525 |
| 131 | MP0004883_abnormal_blood_vessel | 0.72182266 |
| 132 | MP0009046_muscle_twitch | 0.71941297 |
| 133 | MP0002693_abnormal_pancreas_physiology | 0.68744338 |
| 134 | MP0003646_muscle_fatigue | 0.68724324 |
| 135 | MP0002970_abnormal_white_adipose | 0.68190740 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.68087326 |
| 137 | MP0000358_abnormal_cell_content/ | 0.67330754 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.67130999 |
| 139 | MP0005187_abnormal_penis_morphology | 0.66250503 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.65339702 |
| 141 | MP0008007_abnormal_cellular_replicative | 0.65287582 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.65275595 |
| 143 | MP0004085_abnormal_heartbeat | 0.64774161 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.64671773 |
| 145 | MP0005647_abnormal_sex_gland | 0.64536156 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.63029439 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.61730200 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.61100582 |
| 149 | MP0008874_decreased_physiological_sensi | 0.60832341 |
| 150 | MP0002168_other_aberrant_phenotype | 0.59774323 |
| 151 | MP0004264_abnormal_extraembryonic_tissu | 0.59636296 |
| 152 | MP0004782_abnormal_surfactant_physiolog | 0.59480288 |
| 153 | MP0001533_abnormal_skeleton_physiology | 0.58605723 |
| 154 | MP0003953_abnormal_hormone_level | 0.57920557 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.57578128 |
| 156 | MP0008872_abnormal_physiological_respon | 0.57333222 |
| 157 | MP0004947_skin_inflammation | 0.56969120 |
| 158 | MP0000343_altered_response_to | 0.56854838 |
| 159 | MP0004858_abnormal_nervous_system | 0.56212333 |
| 160 | MP0001501_abnormal_sleep_pattern | 0.55800039 |
| 161 | MP0002295_abnormal_pulmonary_circulatio | 0.55242169 |
| 162 | MP0002166_altered_tumor_susceptibility | 0.54911302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.21091793 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.19389678 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.96924163 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.77082622 |
| 5 | Complement deficiency (HP:0004431) | 4.58347120 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.47736023 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.34967857 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 3.96444671 |
| 9 | Hyperglycinuria (HP:0003108) | 3.94366819 |
| 10 | Hypothermia (HP:0002045) | 3.86745153 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85510066 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.83142391 |
| 13 | Hyperammonemia (HP:0001987) | 3.81248580 |
| 14 | Epidermoid cyst (HP:0200040) | 3.73584032 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.68944402 |
| 16 | Ketosis (HP:0001946) | 3.61612675 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.56896098 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.56896098 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54307536 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.52533983 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.40938752 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36449855 |
| 23 | Acute encephalopathy (HP:0006846) | 3.32519830 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.31501093 |
| 25 | Hyperglycinemia (HP:0002154) | 3.29866888 |
| 26 | Abnormality of complement system (HP:0005339) | 3.28978698 |
| 27 | Myocardial infarction (HP:0001658) | 3.22828815 |
| 28 | Progressive macrocephaly (HP:0004481) | 3.21166099 |
| 29 | Acute necrotizing encephalopathy (HP:0006965) | 3.16278559 |
| 30 | Oligomenorrhea (HP:0000876) | 3.16027497 |
| 31 | Joint hemorrhage (HP:0005261) | 3.12100394 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.11691901 |
| 33 | Fat malabsorption (HP:0002630) | 3.00724364 |
| 34 | Ketoacidosis (HP:0001993) | 2.99618630 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.94574518 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.93457816 |
| 37 | Skin nodule (HP:0200036) | 2.91879989 |
| 38 | Increased CSF lactate (HP:0002490) | 2.88277246 |
| 39 | Hypoplasia of the fovea (HP:0007750) | 2.86313876 |
| 40 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.86313876 |
| 41 | Abnormality of glycolysis (HP:0004366) | 2.85167753 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82229531 |
| 43 | Hypercholesterolemia (HP:0003124) | 2.80787230 |
| 44 | Hepatic necrosis (HP:0002605) | 2.79974838 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.78308449 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.77620652 |
| 47 | Abnormality of proline metabolism (HP:0010907) | 2.73846688 |
| 48 | Hydroxyprolinuria (HP:0003080) | 2.73846688 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.73196192 |
| 50 | Methylmalonic acidemia (HP:0002912) | 2.70090548 |
| 51 | Abnormality of vitamin B metabolism (HP:0004340) | 2.69676687 |
| 52 | Neoplasm of the adrenal gland (HP:0100631) | 2.69122216 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.68500885 |
| 54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68125628 |
| 55 | Gout (HP:0001997) | 2.67866052 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.60316723 |
| 57 | Albinism (HP:0001022) | 2.57272821 |
| 58 | Hepatocellular necrosis (HP:0001404) | 2.52043530 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.51057760 |
| 60 | Tongue fasciculations (HP:0001308) | 2.47909982 |
| 61 | Sensorimotor neuropathy (HP:0007141) | 2.44939623 |
| 62 | Pancreatic cysts (HP:0001737) | 2.44092486 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.42534050 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.42379401 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42379401 |
| 66 | Hypertriglyceridemia (HP:0002155) | 2.41949478 |
| 67 | Abnormality of nucleobase metabolism (HP:0010932) | 2.41778650 |
| 68 | Hamartoma of the eye (HP:0010568) | 2.38763573 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.38372026 |
| 70 | Glycosuria (HP:0003076) | 2.38372026 |
| 71 | Hemorrhage of the eye (HP:0011885) | 2.37674577 |
| 72 | Abnormality of the fovea (HP:0000493) | 2.36938927 |
| 73 | Amyloidosis (HP:0011034) | 2.35889016 |
| 74 | Methylmalonic aciduria (HP:0012120) | 2.35746448 |
| 75 | Pancreatitis (HP:0001733) | 2.35555666 |
| 76 | Metabolic acidosis (HP:0001942) | 2.33510931 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32298194 |
| 78 | Hypomagnesemia (HP:0002917) | 2.32180811 |
| 79 | Symptomatic seizures (HP:0011145) | 2.31391398 |
| 80 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.30653689 |
| 81 | Patchy hypopigmentation of hair (HP:0011365) | 2.29989288 |
| 82 | Hepatocellular carcinoma (HP:0001402) | 2.29319994 |
| 83 | Steatorrhea (HP:0002570) | 2.28715532 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 2.27624080 |
| 85 | Abnormality of the renal cortex (HP:0011035) | 2.26677016 |
| 86 | Cholelithiasis (HP:0001081) | 2.26099583 |
| 87 | Acanthosis nigricans (HP:0000956) | 2.25528348 |
| 88 | Disproportionate short-trunk short stature (HP:0003521) | 2.23605984 |
| 89 | Hyperbilirubinemia (HP:0002904) | 2.23100097 |
| 90 | Neonatal onset (HP:0003623) | 2.22673806 |
| 91 | Lethargy (HP:0001254) | 2.21771683 |
| 92 | Type I transferrin isoform profile (HP:0003642) | 2.21156660 |
| 93 | Posterior subcapsular cataract (HP:0007787) | 2.19596405 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.18399922 |
| 95 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16405071 |
| 96 | Nausea (HP:0002018) | 2.15887026 |
| 97 | Spontaneous abortion (HP:0005268) | 2.14999864 |
| 98 | Large for gestational age (HP:0001520) | 2.14237018 |
| 99 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.14153988 |
| 100 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.14153988 |
| 101 | Neoplasm of the adrenal cortex (HP:0100641) | 2.13784092 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.13710118 |
| 103 | Cholecystitis (HP:0001082) | 2.13586929 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.13586929 |
| 105 | Axonal loss (HP:0003447) | 2.13214837 |
| 106 | Pancreatic fibrosis (HP:0100732) | 2.12027215 |
| 107 | Hyperalaninemia (HP:0003348) | 2.11194301 |
| 108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.11194301 |
| 109 | Abnormality of alanine metabolism (HP:0010916) | 2.11194301 |
| 110 | Renal cortical cysts (HP:0000803) | 2.09513720 |
| 111 | Congenital stationary night blindness (HP:0007642) | 2.08912345 |
| 112 | Intestinal atresia (HP:0011100) | 2.08828283 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 2.07909651 |
| 114 | Ileus (HP:0002595) | 2.07887718 |
| 115 | Lactic acidosis (HP:0003128) | 2.06806322 |
| 116 | Abnormal protein glycosylation (HP:0012346) | 2.06780909 |
| 117 | Abnormal glycosylation (HP:0012345) | 2.06780909 |
| 118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06780909 |
| 119 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06780909 |
| 120 | Esophageal varix (HP:0002040) | 2.06662486 |
| 121 | Ependymoma (HP:0002888) | 2.05284030 |
| 122 | Abnormality of vitamin metabolism (HP:0100508) | 2.04761806 |
| 123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.04751220 |
| 124 | Cerebral edema (HP:0002181) | 2.04548830 |
| 125 | Vomiting (HP:0002013) | 2.03697037 |
| 126 | Medial flaring of the eyebrow (HP:0010747) | 2.03387022 |
| 127 | Respiratory failure (HP:0002878) | 2.03372710 |
| 128 | True hermaphroditism (HP:0010459) | 2.03114938 |
| 129 | White forelock (HP:0002211) | 2.02662912 |
| 130 | Palpitations (HP:0001962) | 2.00810565 |
| 131 | Hyperuricemia (HP:0002149) | 2.00060914 |
| 132 | Increased purine levels (HP:0004368) | 2.00060914 |
| 133 | Generalized aminoaciduria (HP:0002909) | 1.99672972 |
| 134 | Vascular calcification (HP:0004934) | 1.99233670 |
| 135 | Right ventricular cardiomyopathy (HP:0011663) | 1.98387306 |
| 136 | Muscle fibrillation (HP:0010546) | 1.97804393 |
| 137 | Cutaneous melanoma (HP:0012056) | 1.97217704 |
| 138 | Mitral stenosis (HP:0001718) | 1.96898071 |
| 139 | Adrenal hypoplasia (HP:0000835) | 1.95360235 |
| 140 | Breast carcinoma (HP:0003002) | 1.94359609 |
| 141 | Irritability (HP:0000737) | 1.94185117 |
| 142 | Increased serum lactate (HP:0002151) | 1.93914409 |
| 143 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.93677671 |
| 144 | Glomerulonephritis (HP:0000099) | 1.92722153 |
| 145 | Cardiovascular calcification (HP:0011915) | 1.90382849 |
| 146 | Abolished electroretinogram (ERG) (HP:0000550) | 1.89307421 |
| 147 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.89130268 |
| 148 | Late onset (HP:0003584) | 1.88711593 |
| 149 | Myoglobinuria (HP:0002913) | 1.88327833 |
| 150 | CNS demyelination (HP:0007305) | 1.87767919 |
| 151 | Delayed CNS myelination (HP:0002188) | 1.86401094 |
| 152 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86129212 |
| 153 | Malnutrition (HP:0004395) | 1.85932010 |
| 154 | Acanthocytosis (HP:0001927) | 1.85691168 |
| 155 | Thyroiditis (HP:0100646) | 1.84804163 |
| 156 | Hypokinesia (HP:0002375) | 1.84325256 |
| 157 | Polycythemia (HP:0001901) | 1.83278805 |
| 158 | Conjunctival hamartoma (HP:0100780) | 1.82636910 |
| 159 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82604484 |
| 160 | Progressive inability to walk (HP:0002505) | 1.82530333 |
| 161 | Hyperglycemia (HP:0003074) | 1.81195405 |
| 162 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78801749 |
| 163 | Delayed gross motor development (HP:0002194) | 1.78280968 |
| 164 | Spastic diplegia (HP:0001264) | 1.77348226 |
| 165 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.77261014 |
| 166 | Metaphyseal dysplasia (HP:0100255) | 1.77009730 |
| 167 | Abnormality of the gallbladder (HP:0005264) | 1.76399508 |
| 168 | Nephritis (HP:0000123) | 1.76190340 |
| 169 | Abnormal pancreas size (HP:0012094) | 1.75437458 |
| 170 | Growth hormone excess (HP:0000845) | 1.74316795 |
| 171 | Brushfield spots (HP:0001088) | 1.73219572 |
| 172 | Hypoglycemic seizures (HP:0002173) | 1.71772790 |
| 173 | Alkalosis (HP:0001948) | 1.69616719 |
| 174 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.68719054 |
| 175 | Vacuolated lymphocytes (HP:0001922) | 1.67994273 |
| 176 | Protuberant abdomen (HP:0001538) | 1.64613445 |
| 177 | Peritonitis (HP:0002586) | 1.62211370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.21176863 |
| 2 | TRIB3 | 3.68624647 |
| 3 | TRIM28 | 3.47962849 |
| 4 | ERN1 | 3.44019946 |
| 5 | EIF2AK3 | 2.93950271 |
| 6 | ACVR1B | 2.78489625 |
| 7 | FRK | 2.74362386 |
| 8 | SIK1 | 2.70348658 |
| 9 | MST1R | 2.61537236 |
| 10 | BMPR1B | 2.53919400 |
| 11 | WNK3 | 2.32792767 |
| 12 | FGFR4 | 2.30109034 |
| 13 | NUAK1 | 2.27678914 |
| 14 | MAP4K2 | 2.09517325 |
| 15 | STK39 | 2.08195012 |
| 16 | ERBB3 | 2.07289129 |
| 17 | MAP3K2 | 2.01732090 |
| 18 | PLK2 | 2.00219614 |
| 19 | EIF2AK1 | 1.96308036 |
| 20 | MAP2K4 | 1.93508200 |
| 21 | GRK1 | 1.92224599 |
| 22 | MAP3K12 | 1.78383148 |
| 23 | DAPK2 | 1.73157507 |
| 24 | KSR2 | 1.71696462 |
| 25 | MKNK2 | 1.67910218 |
| 26 | LMTK2 | 1.62995820 |
| 27 | BRSK2 | 1.57624420 |
| 28 | PLK3 | 1.56797766 |
| 29 | TNIK | 1.56745909 |
| 30 | BCR | 1.54078268 |
| 31 | CAMK1D | 1.53610369 |
| 32 | MAP2K1 | 1.49923088 |
| 33 | PDK2 | 1.49453072 |
| 34 | NTRK1 | 1.47433582 |
| 35 | SIK3 | 1.43510337 |
| 36 | RIPK1 | 1.43336787 |
| 37 | PDK3 | 1.41753616 |
| 38 | PDK4 | 1.41753616 |
| 39 | MAPKAPK3 | 1.39857932 |
| 40 | STK38L | 1.39274104 |
| 41 | PKN2 | 1.38971908 |
| 42 | MYLK | 1.36272064 |
| 43 | TAOK3 | 1.33922146 |
| 44 | NEK9 | 1.30238951 |
| 45 | BUB1 | 1.27271705 |
| 46 | ADRBK2 | 1.26375303 |
| 47 | ARAF | 1.25886256 |
| 48 | FER | 1.25590731 |
| 49 | ZAK | 1.25098426 |
| 50 | PBK | 1.23562929 |
| 51 | TBK1 | 1.22984555 |
| 52 | CASK | 1.20868384 |
| 53 | ERBB4 | 1.18489143 |
| 54 | LATS1 | 1.17739852 |
| 55 | CSNK1G1 | 1.16538034 |
| 56 | MKNK1 | 1.15915592 |
| 57 | PTK6 | 1.13811650 |
| 58 | JAK1 | 1.08941125 |
| 59 | MAP3K3 | 1.06129923 |
| 60 | INSRR | 1.05938905 |
| 61 | CSNK1G3 | 1.05612486 |
| 62 | JAK2 | 1.05386127 |
| 63 | EPHB1 | 1.05364914 |
| 64 | PDPK1 | 1.03547550 |
| 65 | PHKG2 | 1.01966794 |
| 66 | PHKG1 | 1.01966794 |
| 67 | PRKCE | 1.00536757 |
| 68 | PRKCI | 1.00319573 |
| 69 | CSNK1G2 | 0.99053724 |
| 70 | STK3 | 0.98922209 |
| 71 | RET | 0.98623820 |
| 72 | VRK2 | 0.96465415 |
| 73 | TRPM7 | 0.95967517 |
| 74 | TSSK6 | 0.94933286 |
| 75 | PINK1 | 0.94112747 |
| 76 | CAMK1G | 0.92795149 |
| 77 | MAPK11 | 0.92760817 |
| 78 | ABL2 | 0.92175616 |
| 79 | LATS2 | 0.91674487 |
| 80 | FGFR3 | 0.91041888 |
| 81 | PIK3CG | 0.89115342 |
| 82 | NEK1 | 0.88418237 |
| 83 | PIK3CA | 0.87543221 |
| 84 | TYK2 | 0.82679127 |
| 85 | RIPK4 | 0.82530564 |
| 86 | PRKAA2 | 0.81376938 |
| 87 | FGFR2 | 0.81059261 |
| 88 | MAP2K3 | 0.80463345 |
| 89 | LIMK1 | 0.80042961 |
| 90 | PTK2 | 0.79784866 |
| 91 | MAP3K1 | 0.79545742 |
| 92 | MET | 0.79312597 |
| 93 | CSNK1A1L | 0.78960789 |
| 94 | AKT3 | 0.78851954 |
| 95 | MAP3K9 | 0.78793033 |
| 96 | WEE1 | 0.78306007 |
| 97 | STK24 | 0.77721229 |
| 98 | PDK1 | 0.77334530 |
| 99 | BMPR2 | 0.73793678 |
| 100 | LRRK2 | 0.73670903 |
| 101 | MST4 | 0.73249028 |
| 102 | MAP3K11 | 0.72600094 |
| 103 | MAPK13 | 0.71940391 |
| 104 | GRK5 | 0.71259729 |
| 105 | NLK | 0.71067885 |
| 106 | IRAK3 | 0.70754788 |
| 107 | MINK1 | 0.68364132 |
| 108 | EPHA3 | 0.67600634 |
| 109 | OXSR1 | 0.66057809 |
| 110 | PDGFRA | 0.63525981 |
| 111 | CAMKK2 | 0.62745205 |
| 112 | PLK4 | 0.62585554 |
| 113 | WNK4 | 0.61924800 |
| 114 | GRK6 | 0.61602383 |
| 115 | CAMKK1 | 0.61552704 |
| 116 | STK16 | 0.61305695 |
| 117 | SGK3 | 0.60349875 |
| 118 | TIE1 | 0.59243721 |
| 119 | MAPKAPK5 | 0.59242216 |
| 120 | STK10 | 0.59229527 |
| 121 | TGFBR1 | 0.58378003 |
| 122 | PRKCH | 0.57600234 |
| 123 | BMX | 0.57387571 |
| 124 | TTN | 0.56901081 |
| 125 | EEF2K | 0.56213337 |
| 126 | MAP2K2 | 0.55960213 |
| 127 | ADRBK1 | 0.55548874 |
| 128 | EPHB2 | 0.54417676 |
| 129 | BRSK1 | 0.53371612 |
| 130 | FLT3 | 0.53182282 |
| 131 | PRKACG | 0.52282168 |
| 132 | CAMK2G | 0.51397982 |
| 133 | ROCK1 | 0.50954429 |
| 134 | PRKCG | 0.50834360 |
| 135 | RPS6KA2 | 0.50557699 |
| 136 | PRKAA1 | 0.49574360 |
| 137 | EIF2AK2 | 0.49535702 |
| 138 | OBSCN | 0.49233517 |
| 139 | GSK3A | 0.48254992 |
| 140 | PAK3 | 0.47624544 |
| 141 | PTK2B | 0.47449050 |
| 142 | CDK6 | 0.47138101 |
| 143 | TAF1 | 0.46822306 |
| 144 | DAPK3 | 0.46332923 |
| 145 | SGK223 | 0.46328822 |
| 146 | SGK494 | 0.46328822 |
| 147 | PRKCZ | 0.46086861 |
| 148 | TGFBR2 | 0.44973446 |
| 149 | PLK1 | 0.44798868 |
| 150 | IGF1R | 0.44086348 |
| 151 | ZAP70 | 0.43624888 |
| 152 | IRAK4 | 0.43444452 |
| 153 | MAPK12 | 0.43265209 |
| 154 | CAMK2D | 0.40378909 |
| 155 | NTRK3 | 0.39310354 |
| 156 | DAPK1 | 0.39228040 |
| 157 | EPHA2 | 0.38762245 |
| 158 | TTK | 0.36232346 |
| 159 | MAP3K14 | 0.35998806 |
| 160 | VRK1 | 0.35435004 |
| 161 | MAP3K4 | 0.33958006 |
| 162 | FGFR1 | 0.33803272 |
| 163 | DDR2 | 0.33300870 |
| 164 | CSNK1A1 | 0.31658302 |
| 165 | ABL1 | 0.30535756 |
| 166 | CAMK2A | 0.27544827 |
| 167 | ATM | 0.24640881 |
| 168 | TEC | 0.24580656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47242797 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18127484 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.13171821 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.10147785 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90554897 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70376871 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66504820 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.60701488 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58351809 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.47710362 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45306922 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.41433119 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.32247835 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31959190 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17355032 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14262889 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11036652 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97634304 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96908546 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.84475789 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74716765 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.74452252 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.73103254 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72606941 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72483031 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71857015 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69492872 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67596177 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64830437 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62325905 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61752853 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58439187 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.50665844 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49636648 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44292250 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42517909 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41712332 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.41330517 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36505100 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34442882 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32227696 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31563276 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.26577787 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.25364301 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24778589 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19792845 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17674420 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17225978 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16998106 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.16209215 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09864630 |
| 52 | RNA polymerase_Homo sapiens_hsa03020 | 1.03337013 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01762683 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01116035 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00392648 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.96696785 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96438582 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.93365833 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92531572 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89507611 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81607233 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80052370 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80050533 |
| 64 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79760259 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78354294 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78021739 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77455880 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75585806 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74598846 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74550959 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73414805 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72029727 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71220074 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71083139 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69967905 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.69171999 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68229705 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.66446135 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65373279 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61406920 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60935500 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59960564 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58848173 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56536544 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55899422 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55861867 |
| 87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55845735 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52538589 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.52471995 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51050250 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50807843 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50154105 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.46894729 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46838896 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43452127 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43451119 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42792814 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42547172 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41723216 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41072695 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40771696 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40655829 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.40234276 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.37353349 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.34906582 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31842673 |
| 107 | Mismatch repair_Homo sapiens_hsa03430 | 0.31815604 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31620384 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30724646 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28812213 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27869961 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26791957 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23187943 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22132210 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21445992 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.20796093 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.20134370 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.18299941 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14176959 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.13617677 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.13170130 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12453481 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11879602 |
| 124 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.11720394 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10433195 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10091723 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.09531513 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.07069570 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06764278 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.06143706 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05851521 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.05469855 |
| 133 | Renin secretion_Homo sapiens_hsa04924 | 0.03848452 |
| 134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03482499 |

